CDTX logo

Cidara Therapeutics (CDTX) Non Current Assets

Annual Non Current Assets

$6.17 M
+$3.78 M+158.04%

December 31, 2023

Summary

Performance

1-Year Change

+158.04%

3-Year Change

+91%

5-Year Change

+211.4%

15-Year Change

+352.38%

CDTX Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.71%
CDTX annual long term assets is higher than 32.71% of companies in Healthcare sector

High & Low

All-time High

$6.17 M
CDTX annual long term assets is currently at an all-time high

3-Year Low

$2.39 M
CDTX annual long term assets is currently +158.04% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CDTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 22, 2025
CDTX next annual earnings announcement is scheduled for Apr 22, 2025

OtherCDTXbalance sheetmetrics:

Annual Total Assets

$67.03 M
CDTX annual total assets is $67.03 million

Annual Current Assets

$60.85 M
CDTX annual total current assets is $60.85 million

Annual Total Liabilities

$75.24 M
CDTX annual total liabilities is $75.24 million

Annual Total Long Term Liabilities

$7.82 M
CDTX annual total long term liabilities is $7.82 million

Quarterly Non Current Assets

$5.56 M
+$791.00 K+16.59%

September 30, 2024

Summary

Performance

3-Month Change

+16.59%

1-Year Change

-9.96%

3-Year Change

+147.33%

5-Year Change

+147.33%

CDTX Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.39%
CDTX quarterly long term assets is higher than 30.39% of companies in Healthcare sector

High & Low

All-time High

$6.17 M
CDTX quarterly long term assets is currently -9.96% below its historical high of $6.17 million

3-Year Low

$2.25 M
CDTX quarterly long term assets is currently +147.33% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CDTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 22, 2025
CDTX next earnings announcement is scheduled for Apr 22, 2025

OtherCDTXbalance sheetmetrics:

Quarterly Total Assets

$162.33 M
CDTX quarterly total assets is $162.33 million

Quarterly Current Assets

$156.77 M
CDTX quarterly total current assets is $156.77 million

Quarterly Total Liabilities

$46.70 M
CDTX quarterly total liabilities is $46.70 million

Quarterly Long Term Liabilities

$2.36 M
CDTX quarterly total long term liabilities is $2.36 million

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

CDTX Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+158.0%-10.0%
3 y3 years+91.0%+147.3%
5 y5 years+211.4%+147.3%

CDTX Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+158.0%-10.0%+147.3%
5 y5-yearat high+158.0%-10.0%+147.3%
alltimeall timeat high>+9999.0%-10.0%+555.7%

Cidara Therapeutics Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$5.56 M(+16.6%)
Jun 2024
-
$4.77 M(-18.9%)
Mar 2024
-
$5.88 M(-4.7%)
Dec 2023
$60.85 M(+35.0%)
$6.17 M(+7.1%)
Sep 2023
-
$5.76 M(+0.3%)
Jun 2023
-
$5.75 M(+155.6%)
Mar 2023
-
$2.25 M(-6.1%)
Dec 2022
$45.09 M(-37.1%)
$2.39 M(-19.1%)
Sep 2022
-
$2.96 M(-0.6%)
Jun 2022
-
$2.98 M(-9.4%)
Mar 2022
-
$3.29 M(-9.3%)
Dec 2021
$71.70 M(+25.4%)
$3.63 M(-7.7%)
Sep 2021
-
$3.93 M(+47.3%)
Jun 2021
-
$2.67 M(-8.3%)
Mar 2021
-
$2.91 M(-10.0%)
Dec 2020
$57.19 M(-13.1%)
$3.23 M(-7.2%)
Sep 2020
-
$3.48 M(+3.5%)
Jun 2020
-
$3.36 M(-3.2%)
Mar 2020
-
$3.48 M(+9.9%)
Dec 2019
$65.81 M
$3.16 M(-24.9%)
DateAnnualQuarterly
Sep 2019
-
$4.21 M(+5.0%)
Jun 2019
-
$4.01 M(-0.8%)
Mar 2019
-
$4.04 M(+103.6%)
Dec 2018
$77.13 M(-0.7%)
$1.98 M(+133.8%)
Sep 2018
-
$848.00 K(-16.4%)
Jun 2018
-
$1.01 M(-19.3%)
Mar 2018
-
$1.26 M(-7.9%)
Dec 2017
$77.67 M(-26.3%)
$1.36 M(+10.7%)
Sep 2017
-
$1.23 M(-9.0%)
Jun 2017
-
$1.35 M(-8.6%)
Mar 2017
-
$1.48 M(-5.2%)
Dec 2016
$105.40 M(-2.6%)
$1.56 M(-5.4%)
Sep 2016
-
$1.65 M(-7.8%)
Jun 2016
-
$1.79 M(+5.1%)
Mar 2016
-
$1.71 M(-2.8%)
Dec 2015
$108.22 M(+370.2%)
$1.76 M(+8.2%)
Sep 2015
-
$1.62 M(+79.7%)
Jun 2015
-
$903.00 K(-62.1%)
Mar 2015
-
$2.38 M(+78.1%)
Dec 2014
$23.01 M(>+9900.0%)
$1.34 M
Dec 2013
$198.00 K
-

FAQ

  • What is Cidara Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Cidara Therapeutics?
  • What is Cidara Therapeutics annual non current assets year-on-year change?
  • What is Cidara Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Cidara Therapeutics?
  • What is Cidara Therapeutics quarterly non current assets year-on-year change?

What is Cidara Therapeutics annual long term assets?

The current annual non current assets of CDTX is $6.17 M

What is the all time high annual non current assets for Cidara Therapeutics?

Cidara Therapeutics all-time high annual long term assets is $6.17 M

What is Cidara Therapeutics annual non current assets year-on-year change?

Over the past year, CDTX annual long term assets has changed by +$3.78 M (+158.04%)

What is Cidara Therapeutics quarterly long term assets?

The current quarterly non current assets of CDTX is $5.56 M

What is the all time high quarterly non current assets for Cidara Therapeutics?

Cidara Therapeutics all-time high quarterly long term assets is $6.17 M

What is Cidara Therapeutics quarterly non current assets year-on-year change?

Over the past year, CDTX quarterly long term assets has changed by -$615.00 K (-9.96%)